BKHA

Conviction 17HealthcareScan · Tue, Oct 13, 2026

Bearish marubozu

Black Hawk Acquisition Corp (BKHA) closed at $12.30 (-5.38%) on Oct 13, 2026. Its latest daily candle is a bearish marubozu. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, -6.1% from its 52-week high, +9.2% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

BKHA$12.30-5.38%

ResistanceSupportVol 14

Vol MA14 28.33K

Jan 16Mar 30Jun 8Jul 30Sep 22Oct 13

Why BKHA moved

From the StockSetups movers recaps that covered BKHA, newest first. A recap states what was known that day.

Oct 13, 2026After hours+12.0%
Black Hawk rose 12.0% after hours to $13.78 on 200,159 shares, about ten times its 20-day average of 20,024. Market cap is $51.1M. This is a SPAC, a shell company that merges with an operating business.
After-Hours Movers Oct 13, 2026: Why LQDA, TCRT, YJ Jumped →

Black Hawk Acquisition CorpBiological Products, (No Diagnostic Substances)www.bhspac.com ↗

Price12.30

Change-5.38%

Gap+5.77%

Rel volume0.34×

Avg volume20.02K

Avg $ vol248.2K

SMA 2012.19

SMA 5012.03

SMA 20011.11

Price vs 50+2.23%

Price vs 200+10.69%

MA stackbullish

50/200 cross—

Supertrenddown · 13.25

RSI (14)51

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D7 / 7

ADX (14)50

+DI / −DI68 / 5

RSI divergence—

MACD divergence—

ATR %9.50%

ADR %6.79%

52w high13.10

52w low10.13

From 52w high-6.11%

Above 52w low+21.37%

New 52w highNo

SqueezeOn · 2d

Bollinger width11.52%

%B0.58

Donchian pos6.71%

Donchian high23.00

Donchian low11.53

AVWAP (52w high)15.57

vs AVWAP high-21.01%

AVWAP (52w low)10.80

vs AVWAP low+13.89%

OBV trendUp

Chaikin MF (20)-0.45

Today vs 20d0.34×

Avg vol (14d)28.33K

Avg vol (20d)20.02K

Avg $ vol (20d)248.2K

Market cap51.09M

RS Rating—

RS 3m (vs SPY)-7.89%

RS 6m (vs SPY)-15.97%

RS line new highNo

Trend template—

Technical rank82.7

1 week+0.16%

1 month+3.97%

3 months+4.50%

6 months+16.04%

1 year—

YTD+9.24%

P/E38.43

P/B-10.85

P/S—

P/FCF—

EPS—

Div yield—

ROE-28.23%

ROA5.11%

Debt/Eq—

Current0.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-30.60%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value51.09M

Revenue—

Net income1.07M

Gross profit—

Free cash flow—

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out4.15M

Employees—

ListedMon, May 13, 2024

Free float2.19M

Float %52.8%

Short interest316

Days to cover0.4d

Short volume50.0%

Squeeze score9 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction17 / 100

Pattern quality—

Tech rank82.7 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

Financials as of Mon, Aug 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BKHA

All disclosures →

No recent disclosed trades by Congress in BKHA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BKHA

No recent insider (Form 4) filings in BKHA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BKHA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

BKHA

Why BKHA moved

Recent news

Get daily signals & real-time alerts.